These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 17439910
1. The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study. Scherer P, Penner IK, Rohr A, Boldt H, Ringel I, Wilke-Burger H, Burger-Deinerth E, Isakowitsch K, Zimmermann M, Zahrnt S, Hauser R, Hilbert K, Tiel-Wilck K, Anvari K, Behringer A, Peglau I, Friedrich H, Plenio A, Benesch G, Ehret R, Nippert I, Finke G, Schulz I, Bergtholdt B, Breitkopf S, Kaskel P, Reischies F, Kugler J. Mult Scler; 2007 Apr; 13(3):402-11. PubMed ID: 17439910 [Abstract] [Full Text] [Related]
2. Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test. Claesson IM, Ytterberg C, Johansson S, Almkvist O, von Koch L. Mult Scler; 2007 Mar; 13(2):272-4. PubMed ID: 17439898 [Abstract] [Full Text] [Related]
3. Brain activation patterns elicited by the 'Faces Symbol Test' -- a pilot fMRI study. Grabner R, Popotnig F, Ropele S, Neuper C, Gorani F, Petrovic K, Ebner F, Strasser-Fuchs S, Fazekas F, Enzinger C. Mult Scler; 2008 Apr; 14(3):354-63. PubMed ID: 18208887 [Abstract] [Full Text] [Related]
4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B. Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [Abstract] [Full Text] [Related]
6. Cognitive impairment and decline in different MS subtypes. Huijbregts SC, Kalkers NF, de Sonneville LM, de Groot V, Polman CH. J Neurol Sci; 2006 Jun 15; 245(1-2):187-94. PubMed ID: 16643951 [Abstract] [Full Text] [Related]
11. A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis. Portaccio E, Goretti B, Zipoli V, Siracusa G, Sorbi S, Amato MP. Clin Neuropsychol; 2009 Feb 15; 23(2):268-75. PubMed ID: 18609336 [Abstract] [Full Text] [Related]
12. [Sleepiness and fatigue in multiple sclerosis - comparison of different measuring instruments]. Kotterba S, Eren E, Fangerau T, Malin JP, Sindern E. Fortschr Neurol Psychiatr; 2003 Nov 15; 71(11):590-4. PubMed ID: 14608510 [Abstract] [Full Text] [Related]
15. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis. Sastre-Garriga J, Arévalo MJ, Renom M, Alonso J, González I, Galán I, Montalban X, Rovira A. J Neurol Sci; 2009 Jul 15; 282(1-2):120-4. PubMed ID: 19157420 [Abstract] [Full Text] [Related]
16. Paced visual serial addition test in multiple sclerosis. Nagels G, Geentjens L, Kos D, Vleugels L, D'hooghe MB, Van Asch P, Vuylsteke K, De Deyn PP. Clin Neurol Neurosurg; 2005 Apr 15; 107(3):218-22. PubMed ID: 15823678 [Abstract] [Full Text] [Related]
17. The Face-Symbol Test and the Symbol-Digit Test are not reliable surrogates for the Paced Auditory Serial Addition Test in multiple sclerosis. Williams J, O'Rourke K, Hutchinson M, Tubridy N. Mult Scler; 2006 Oct 15; 12(5):599-604. PubMed ID: 17086906 [Abstract] [Full Text] [Related]
19. Relationship of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) to functional, emotional, and neuropsychological outcomes. O'Brien A, Gaudino-Goering E, Shawaryn M, Komaroff E, Moore NB, DeLuca J. Arch Clin Neuropsychol; 2007 Nov 15; 22(8):933-48. PubMed ID: 17851031 [Abstract] [Full Text] [Related]
20. Neuropsychological testing and event-related potentials in the assessment of cognitive performance in the patients with multiple sclerosis--a pilot study. Pokryszko-Dragan A, Zagrajek M, Slotwinski K, Gruszka E, Bilinska M, Podemski R. Clin Neurol Neurosurg; 2009 Jul 15; 111(6):503-6. PubMed ID: 19233546 [Abstract] [Full Text] [Related] Page: [Next] [New Search]